Navigation Links
Chemspec International Limited Announces Share Repurchase Program
Date:9/22/2010

Chemspec International Limited Announces Share Repurchase Program -- SHANGHAI, Sept. 22 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Consumer Electronics, Pharmaceuticals, Agriculture, Chemical Click to view news release full screen  

Chemspec International Limited Announces Share Repurchase Program

 

SHANGHAI, Sept. 22 /PRNewswire-Asia-FirstCall/ -- Chemspec International Limited (NYSE: CPC; "Chemspec" or the "Company"), a leading China-based contract manufacturer of highly-engineered specialty chemicals, today announced that its board of directors has authorized a share repurchase program that would allow the Company to repurchase up to US$10 million of its American Depositary Shares ("ADSs") on the open market between September 22, 2010 and September 21, 2011.

The repurchases will be made from time to time on the open market at prevailing market prices. The timing and extent of any purchases will depend upon market conditions, the trading price of the ADSs and other factors, and will be subject to restrictions relating to volume, price and timing under applicable laws, including Rule 10b-18 of the Securities Exchange Act of 1934.

Commenting on the ADS repurchase program, Dr. Jianhua Yang, Chairman and Chief Executive Officer of Chemspec, said, "Our board of directors believes that the repurchase program is an effective use of cash to enhance value for our shareholders and demonstrate our confidence in the long-term health and future financial performance of our business."

Chemspec expects to implement this share repurchase program in a manner that is consistent with market conditions, and always in the interest of the Company's shareholders. Chemspec's board of directors will review the share repurchase program periodically, and may authorize adjustments, both in terms of size and conditions, accordingly.

About Chemspec

Chemspec is a leading China-based contract manufacturer of highly engineered specialty chemicals as well as fluorinated specialty chemicals. In manufacturing specialty chemicals, Chemspec also provides process design and process development services, which enable efficient and rapid production of specialty chemicals that are incorporated into the products of Chemspec's end users. Chemspec's customers and end users include electronics, pharmaceutical and agrochemical companies. For more information, please visit http://www.chemspec.com.cn .

Safe Harbor Statements

This announcement contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in Chemspec's filings with the U.S. Securities and Exchange Commission, including its registration statement on Form F-1, as amended from time to time. Chemspec does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For further information, please contact: Chemspec International Ltd. In Shanghai Carol Fang Manager, Investor Relations Tel: +86-21-6363-8108 Email: ir@chemspec.com.cn Christensen In New York Kathy Li Tel: +1-212-618-1978 Email: kli@christensenir.com In Hong Kong Tip Fleming Tel: +852-9212-0684 Email: tfleming@christensenir.com
'/>"/>

SOURCE Chemspec International Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mettler-Toledo International Inc. Announces Webcast of Presentation at UBS Global Life Sciences Conference
2. GBS/CIDP Foundation to Hold 11th International Symposium
3. Sono-Tek Presents at the 15th International Coating Science and Technology Symposium (ISCST, St. Paul, MN)
4. Reportlinker Adds Pharmaceutical Preparation Manufacturing Industry in the U.S. and Its International Trade [Q3 2010 Edition]
5. Max Neeman International Expands Upon Cardiology and Device Trial Experience to Meet Increased Medical Device Development in India
6. PRA Internationals Drug Safety Experts to Speak at Safety Congress
7. Biosystems International Merges With Microbiochips
8. Medizone International Files For Additional Bio-Terrorism Countermeasures Patent Protection
9. International Isotopes Inc. Announces Completion of a Licensing and Permitting Assistance Agreement with URENCO USA
10. Dyadic International and EnGen Bio to Present at Rodman & Renshaw Annual Global Investment Conference
11. Dyadic International Raises Additional $1 Million to Complete $4 Million Convertible Note Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... -- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an ... Puerto Rico , where the company ... Following a comprehensive onsite assessment, ... damage, temporary loss of power and minimal water damage ... operations have resumed, and the company expects to return ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
Breaking Medicine News(10 mins):